Outcomes4Me
Oncology Clinical Trial Finder
Breast Cancer
Location

Recruiting • Phase NA • Stage 0, I, II, III • Surgical • Post-Menopausal • Brain Metastases absent • Interventional

The following is imported from ClinicalTrials.gov:

A Culturally Sensitive Social Support Intervention

This study is a randomized controlled trial (RCT) to assess the impact of a culturally based social support program (i.e. Joy Luck Academy, JLA) among Chinese American breast cancer survivors.

This study is a randomized controlled trial (RCT) to test the health benefits of an education and peer mentor support intervention. Chinese American breast cancer survivors who have completed primary treatment will be randomly assigned to either the intervention group or a control group to receive enhanced usual care while waiting for the JLA. Health outcomes are assessed at baseline, immediately post intervention, and 1 and 4 months follow-ups.

Breast Cancer

Study Design
Study type:

Interventional

Estimated enrollment:

168 participant

Actual study start date:

January 20, 2015

Eligibility Criteria
Ages eligible for study:

18 - 999

Sexes eligible for study:

female


Arms and Intervention
  • Social support intervention

Inclusion criteria
  • self-identified to be comfortable speaking chinese (mandarin or cantonese)

  • having a first breast cancer diagnosis of stages 0-iii

  • having completed primary treatment (surgery, chemotherapy, or radiotherapy) within the last 36 months

Exclusion criteria
  • unable to read or speak chinese (mandarin or cantonese)

  • breast cancer diagnosis of stage iv

  • live outside of the la area

Trial Information at Site
Last Updated:
Trial Information
ClinicalTrial.gov ID:

Recruiting

Estimated Enrollment:

168

Last Updated:

02/24/2024


Site Contact

Alice Loh

626-286-2600

Herald Cancer Association

Los Angeles, California, United States, 91776


Trial Contact

Qian Lu, PhD; MD

qlu@mdanderson.org

713-745-8324


Lenna Dawkins-Moultin, PhD

ldawkins@mdanderson.org

713-792-0005


Principal Investigator

Qian Lu, PhD; MD


Trial Sponsor

M.D. Anderson Cancer Center

Study Location (1)

Herald Cancer Association

Los Angeles, California, United States

Outcomes4Me

© 2024 Outcomes4Me Inc. All rights reserved.